• Users Online: 211
  • Print this page
  • Email this page


 
 
Table of Contents
CME TEST
Year : 2020  |  Volume : 31  |  Issue : 1  |  Page : 43-44

CME Test


Date of Web Publication20-Feb-2020

Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1879-5226.278880

Get Permissions


How to cite this article:
. CME Test. Urol Sci 2020;31:43-4

How to cite this URL:
. CME Test. Urol Sci [serial online] 2020 [cited 2020 Apr 2];31:43-4. Available from: http://www.e-urol-sci.com/text.asp?2020/31/1/43/278880




  CME Test Top


Please read this issue of Urological Science and return the postage-paid reply slip with your answers by April, 2020. A score of 80% or better will earn two CME credits. Questions/answers:

  1. The response rate of the advanced clear cell renal cell carcinoma to PD-1/PD-L1 blockade alone is?


    1. 0-10%
    2. 20-30%
    3. 40-50%
    4. 70-80%
    5. 90-100%


    Urol Sci 2020:31(1):4-7.

  2. The Immunotherapy for advanced renal cell carcinoma included?


    1. Interferon-alpha
    2. Interleukin-2
    3. cytotoxic T-lymphocyte–associated antigen-4 inhibitor
    4. programmed death 1 inhibitor/ programmed death-ligand 1 inhibitor
    5. all of the above


    Urol Sci 2020:31(1):8-14.

  3. The adverse effects of adrogen deprivation therapy for prostate cancer included?


    1. poorer quality of life
    2. sexual dysfunction
    3. fatigue
    4. loss of bone intensity and muscle atrphy


    5. all of the above


    Urol Sci 2020:31(1):15-20.

  4. What is the prevalence of moderate to severe lower urinary tract symptoms in patients with prostate cancer scheduled for prostatectomy?


    1. 10-20%
    2. 20-30%
    3. 44-57%
    4. 70-80%
    5. 90-100%


    Urol Sci 2020:31(1):21-27.



  5. The lower urinary tract symptoms(LUTS) of patients with localized PCa exacerbated immediately after treatment. When will the LUTS returns to the baseline for men without LUTS pretreatment?


    1. 1-7 days
    2. Several weeks
    3. 1-6 months.
    4. 6-18 months.
    5. 2-3 years


Urol Sci 2020:31(1):21-27.

Volume 30 Issue 6

Answers:

1. (C) 2. (D) 3. (A) 4. (C) 5. (C)






 

Top
 
  Search
 
    Similar in PUBMED
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
CME Test

 Article Access Statistics
    Viewed90    
    Printed1    
    Emailed0    
    PDF Downloaded18    
    Comments [Add]    

Recommend this journal